{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:00:11Z","timestamp":1793073611982,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Bone accrual in childhood determines bone health in later life. Loss of bone strength in early life can lead to increased morbidity and reduced quality of life in childhood and adolescence. Increased availability of assessment tools and bisphosphonate therapy, together with increased awareness on the significance of fracture history and risk factors, have led to greater opportunities, to improve detection and optimize management of children and adolescents with bone fragility globally, including those in lower resource settings. Bone mineral density z-scores and bone mineral content are surrogate measures of bone strength, which can be measured by dual-energy X-ray absorptiometry (DXA), in growing individuals. DXA can aid in the diagnosis and management of primary and secondary bone fragility disorders in childhood. DXA helps evaluate children with clinically significant fractures, and monitor those with bone fragility disorders, or at high risk for compromised bone strength. Obtaining DXA images can however be challenging, especially in younger children, due to difficulty in positioning and movement artefacts, while paediatric DXA interpretation can be confounded by effects of growth and puberty. Furthermore, access to DXA facilities as well as appropriate paediatric reference norms and expertise for interpretation, may not be easily available especially in lower resource settings. Pediatric bone experts are now placing increasing emphasis on the fracture phenotype and clinical context to diagnose osteoporosis over bone mineral density (BMD) by DXA. Low trauma vertebral fractures are now recognized as a hallmark of bone fragility, and spinal fracture surveillance by either conventional lateral thoracolumbar radiographs or vertebral fracture assessment by DXA is gaining increasing importance in diagnosing childhood osteoporosis, and initiating bone protective therapy. Furthermore, it is now understood that even a single, low-trauma long bone fracture can signal osteoporosis in those with risk factors for bone fragility. Intravenous bisphosphonate therapy is the mainstay of treatment for childhood bone fragility disorders. Other supportive measures to improve bone strength include optimizing nutrition, encouraging weight bearing physical activity within the limits of the underlying condition, and treating any associated endocrinopathies. With this paradigm shift in childhood osteoporosis evaluation and management, lack of DXA facilities to assess BMD at baseline and\/or provide serial monitoring is not a major barrier for initiating IV bisphosphonate therapy in children in whom it is clinically indicated and would benefit from its use. DXA is useful, however, to monitor treatment response and optimal timing for treatment discontinuation in children with transient risk factors for osteoporosis. Overall, there is lack of awareness and paucity of guidelines on utilizing and adopting available resources to manage paediatric bone disorders optimally in lower-resource settings. We provide an evidence-based approach to the assessment and management of bone fragility disorders in children and adolescents, with appropriate considerations for lower resource settings including LMIC countries.<\/jats:p>","DOI":"10.3389\/fendo.2023.1082413","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:49:02Z","timestamp":1681710542000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Bone health in childhood and adolescence: an overview on dual-energy X-ray absorptiometry scanning, fracture surveillance and bisphosphonate therapy for low-middle-income countries"],"prefix":"10.3389","volume":"14","author":[{"given":"Dilki","family":"Madhuchani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumudu Nimali","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MED.0000000000000124","article-title":"An update on childhood bone health: mineral accrual, assessment and treatment","volume":"22","author":"Sopher","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jocd.2020.01.006","article-title":"DXA in children and adolescents","volume":"24","author":"Guss","year":"2021","journal-title":"J Clin Densitom"},{"key":"B3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11684-020-0748-y","article-title":"Factors influencing peak bone mass gain","volume":"15","author":"Zhu","year":"2021","journal-title":"Front Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2016.12.013","article-title":"DXA: 30years and counting: introduction to the 30th anniversary issue","volume":"104","author":"Lewiecki","year":"2017","journal-title":"Bone"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2007.057505","article-title":"The role of DXA bone density scans in the diagnosis and treatment of osteoporosis","volume":"83","author":"Blake","year":"2007","journal-title":"Postgrad Med J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bone.2016.12.008","article-title":"Use of dual energy X-ray absorptiometry in pediatric patients","volume":"104","author":"Wasserman","year":"2017","journal-title":"Bone"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2010.01.121","article-title":"Assessing body composition in healthy newborn infants: Reliability of dual-energy x-ray absorptiometry","volume":"13","author":"Godang","year":"2010","journal-title":"J Clin Densitom"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e32830b5f23","article-title":"Assessment methods in human body composition","volume":"11","author":"Lee","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.13768","article-title":"Consensus guidelines on the use of bisphosphonate therapy in children and adolescents","volume":"54","author":"Simm","year":"2018","journal-title":"J Paediatr Child Health"},{"key":"B10","first-page":"2","article-title":"Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases","volume":"7","author":"Francis","year":"2007","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"B11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40200-014-0109-y","article-title":"Bisphosphonate therapy in pediatric patients","volume":"13","author":"Eghbali-Fatourechi","year":"2014","journal-title":"J Diabetes Metab Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3447","article-title":"Bone morbidity and recovery in children with acute lymphoblastic leukemia: Results of a six-year prospective cohort study","volume":"33","author":"Ward","year":"2018","journal-title":"J Bone Mineral Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090202","article-title":"Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian steroid-associated osteoporosis in the pediatric population (STOPP) research program","volume":"24","author":"Halton","year":"2009","journal-title":"J Bone Miner Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2019.07.001","article-title":"Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics","volume":"22","author":"Shuhart","year":"2019","journal-title":"J Clin Densitometry"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-022-04455-2","article-title":"Osteoporosis in children and adolescents: When to suspect and how to diagnose it","volume":"181","author":"Ciancia","year":"2022","journal-title":"Eur J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2935","article-title":"Amalgamated reference data for size-adjusted bone densitometry measurements in 3598 children and young adults\u2013the ALPHABET study","volume":"32","author":"Crabtree","year":"2017","journal-title":"J Bone mineral Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2553","article-title":"The bone mineral density in childhood study: Bone mineral content and density according to age, sex, and race","volume":"92","author":"Kalkwarf","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2019.07.002","article-title":"The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: 2019 ISCD official position","volume":"22","author":"Weber","year":"2019","journal-title":"J Clin Densitometry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2020.07.002","article-title":"Bone health in childhood chronic disease","volume":"49","author":"Weber","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12969-020-0411-9","article-title":"Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children","volume":"18","author":"Galindo-Zavala","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3515-9","article-title":"The management of osteoporosis in children","volume":"27","author":"Ward","year":"2016","journal-title":"Osteoporos Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-021-00691-x","article-title":"Bone health in pediatric patients with IBD: What is new","volume":"19","author":"Gordon","year":"2021","journal-title":"Curr Osteoporosis Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12969-021-00521-5","article-title":"Growth and puberty in children with juvenile idiopathic arthritis","volume":"19","author":"d'Angelo","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00173-X","article-title":"Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the international late effects of childhood cancer guideline harmonization group","volume":"9","author":"Van Atteveld","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-021-00667-x","article-title":"Which child with a chronic disease needs bone health monitoring","volume":"19","author":"Ward","year":"2021","journal-title":"Curr Osteoporos Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010429.pub2","article-title":"Treatment for osteoporosis in people with \u00df-thalassaemia","volume":"10","author":"Bhardwaj","year":"2016","journal-title":"Cochrane Database Systematic Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz294","article-title":"A contemporary view of the definition and diagnosis of osteoporosis in children and adolescents","volume":"105","author":"Ward","year":"2019","journal-title":". J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-021-00672-0","article-title":"Part 2: when should bisphosphonates be used in children with chronic illness osteoporosis","volume":"19","author":"Ward","year":"2021","journal-title":"Curr Osteoporos Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00576","article-title":"Glucocorticoid induced osteoporosis: why kids are different","volume":"11","author":"Ward","year":"2020","journal-title":"Front Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone mineral Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650110716","article-title":"Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis","volume":"11","author":"Genant","year":"1996","journal-title":"J Bone Mineral Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1178","article-title":"Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry","volume":"91","author":"Lewiecki","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2054","article-title":"Single-dose pharmacokinetics and tolerability of alendronate 35- and 70-milligram tablets in children and adolescents with osteogenesis imperfecta type I","volume":"90","author":"Ward","year":"2005","journal-title":". J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12560","article-title":"Treatment of glucocorticoid-induced low bone mineral density in children: A systematic review","volume":"18","author":"Jayasena","year":"2015","journal-title":"Int J Rheumatic Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"115914","DOI":"10.1016\/j.bone.2021.115914","article-title":"Osteogenesis imperfecta in children","volume":"148","author":"Arshad","year":"2021","journal-title":"Bone"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2013.12.001","article-title":"Cyclic pamidronate infusion for neonatalonset osteogenesis imperfecta","volume":"55","author":"Lin","year":"2014","journal-title":"Pediatr Neonatology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1082413\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:49:04Z","timestamp":1681710544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1082413\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":37,"alternative-id":["10.3389\/fendo.2023.1082413"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1082413","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"article-number":"1082413"}}